Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06975059 · ClinicalTrials.gov registry record · NA
Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients
A NA study of Parkinson's Disease (PD), sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06975059 is a NA study of Parkinson's Disease (PD) that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 40 participants, below the 47-participant average among 4 other Parkinson's Disease (PD) trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06975059, a NA study of Parkinson's Disease (PD), is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Gait changes in Parkinson's disease are complex, variable, and difficult to detect during short clinic assessments. The aim of this study is to collect gait measurements in Parkinson's patients through sensors in a novel shoe device, NUSHU by Magnes AG. The shoe additionally provides vibrational feedback that can potentially help gait difficulties experienced by Parkinson's patients.
Conditions Studied
Interventions
- DEVICE NUSHU shoe
Study Locations (1)
New York
- Weill Cornell - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-05-30 |
| Est. Completion | 2030-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06975059
The ClinicalTrials.gov registry entry for NCT06975059 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 47-participant average among 4 other Parkinson's Disease (PD) trials with a reported enrollment target (15% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson's Disease (PD) appearing as the primary indexed condition, and to 1 intervention - of which NUSHU shoe is the first listed.
NCT06975059 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06975059 about?
NCT06975059 is a clinical study titled "Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients". Gait changes in Parkinson's disease are complex, variable, and difficult to detect during short clinic assessments. The aim of this study is to collect gait measurements in Parkinson's patients through sensors in a novel shoe device, NUSHU by Magnes AG. The shoe additionally provides vibrational fee...
What is the current status of trial NCT06975059?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-05-30. Estimated completion is 2030-07.
What conditions does trial NCT06975059 study?
This clinical trial studies the following conditions: Parkinson's Disease (PD).
What interventions are being tested in trial NCT06975059?
The interventions under investigation include: NUSHU shoe (DEVICE).
Who is sponsoring clinical trial NCT06975059?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06975059 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease (PD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Accelerated TMS for Freezing of Gait in Parkinson's Disease
RECRUITING · NA
-
Attention and Eye Movement in Parkinson's Disease
RECRUITING · NA
-
Effects of Transcranial Ultrasound Stimulation (TUS) on Neurological and Cognitive Outcomes in Neurodegenerative Diseases
RECRUITING · NA
-
Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.